Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
United States Oil Fund LP
USO
No Data
Tyra Biosciences to Participate in Upcoming Investor Conferences
Buy Rating on Tyra Biosciences Backed by Dabogratinib's Potential to Redefine Intermediate-Risk Bladder Cancer Treatment Ahead of Key Phase II SURF302 Data
William Blair Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating
Tyra Bioscience Expands Board, Appoints New Independent Director
Express News | Tyra Biosciences Announces Appointment of Habib Dable to Its Board of Directors
Tyra Biosciences Advances Dabogratinib Trial in Niche Urothelial Cancer: What Investors Should Watch